BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol. 2006;290:G827-G838. [PMID: 16537974 DOI: 10.1152/ajpgi.00513.2005] [Cited by in Crossref: 385] [Cited by in F6Publishing: 375] [Article Influence: 25.7] [Reference Citation Analysis]
Number Citing Articles
1 Morrison PJ, Ballantyne SJ, Macdonald SJ, Moore JW, Jenkins D, Wright JF, Fouser LA, Kullberg MC. Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. Am J Pathol. 2015;185:3290-3303. [PMID: 26458765 DOI: 10.1016/j.ajpath.2015.08.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Delbue D, Lebenheim L, Cardoso-Silva D, Dony V, Krug SM, Richter JF, Manna S, Muñoz M, Wolk K, Heldt C, Heimesaat MM, Sabat R, Siegmund B, Schumann M. Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22. Front Med (Lausanne) 2021;8:656047. [PMID: 33912578 DOI: 10.3389/fmed.2021.656047] [Reference Citation Analysis]
3 Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 2010;6:e1000902. [PMID: 20485566 DOI: 10.1371/journal.ppat.1000902] [Cited by in Crossref: 345] [Cited by in F6Publishing: 307] [Article Influence: 31.4] [Reference Citation Analysis]
4 Kmieć Z, Cyman M, Ślebioda TJ. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 2017;62:1-16. [PMID: 28126697 DOI: 10.1016/j.advms.2016.09.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 13.3] [Reference Citation Analysis]
5 Che Y, Su Z, Xia L. Effects of IL-22 on cardiovascular diseases. International Immunopharmacology 2020;81:106277. [DOI: 10.1016/j.intimp.2020.106277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Kempski J, Brockmann L, Gagliani N, Huber S. TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis. Front Immunol 2017;8:1373. [PMID: 29118756 DOI: 10.3389/fimmu.2017.01373] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
7 Brand S, Dambacher J, Beigel F, Zitzmann K, Heeg MH, Weiss TS, Prüfer T, Olszak T, Steib CJ, Storr M. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1019-G1028. [PMID: 17204547 DOI: 10.1152/ajpgi.00239.2006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
8 Li XH, Chen JX, Yue GX, Liu YY, Zhao X, Guo XL, Liu Q, Jiang YM, Bai MH. Gene expression profile of the hippocampus of rats subjected to chronic immobilization stress. PLoS One 2013;8:e57621. [PMID: 23544040 DOI: 10.1371/journal.pone.0057621] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
9 Shui JW, Larange A, Kim G, Vela JL, Zahner S, Cheroutre H, Kronenberg M. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 2012;488:222-5. [PMID: 22801499 DOI: 10.1038/nature11242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 9.9] [Reference Citation Analysis]
10 Ventevogel MS, Sempowski GD. Thymic rejuvenation and aging. Curr Opin Immunol 2013;25:516-22. [PMID: 23831111 DOI: 10.1016/j.coi.2013.06.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
11 Huo HJ, Chen SN, Laghari ZA, Li L, Hou J, Gan Z, Huang L, Li N, Nie P. Specific bioactivity of IL-22 in intestinal cells as revealed by the expression of IL-22RA1 in Mandarin fish, Siniperca chuatsi. Dev Comp Immunol 2021;121:104107. [PMID: 33878363 DOI: 10.1016/j.dci.2021.104107] [Reference Citation Analysis]
12 Lavoie TN, Carcamo WC, Wanchoo A, Sharma A, Gulec A, Berg KM, Stewart CM, Nguyen CQ. IL-22 regulation of functional gene expression in salivary gland cells. Genom Data 2016;7:178-84. [PMID: 26981401 DOI: 10.1016/j.gdata.2015.11.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Wang Z, Yang L, Jiang Y, Ling ZQ, Li Z, Cheng Y, Huang H, Wang L, Pan Y, Wang Z. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS One. 2011;6:e23737. [PMID: 21897855 DOI: 10.1371/journal.pone.0023737] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
14 Stefanich EG, Rae J, Sukumaran S, Lutman J, Lekkerkerker A, Ouyang W, Wang X, Lee D, Danilenko DM, Diehl L, Loyet KM, Herman A. Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochem Pharmacol 2018;152:224-35. [PMID: 29608910 DOI: 10.1016/j.bcp.2018.03.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
15 Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007;178:2229-40. [PMID: 17277128 DOI: 10.4049/jimmunol.178.4.2229] [Cited by in Crossref: 353] [Cited by in F6Publishing: 318] [Article Influence: 25.2] [Reference Citation Analysis]
16 Aktas Cetin E, Cosan F, Cefle A, Deniz G. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease. Mod Rheumatol 2014;24:802-7. [PMID: 24498963 DOI: 10.3109/14397595.2013.879414] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
17 Dambacher J, Beigel F, Seiderer J, Haller D, Göke B, Auernhammer CJ, Brand S. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 2007;56:1257-65. [PMID: 17449633 DOI: 10.1136/gut.2006.118679] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
18 Jones BC, Logsdon NJ, Walter MR. Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008;64:266-9. [PMID: 18391423 DOI: 10.1107/S1744309108004752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev. 2010;21:435-441. [PMID: 21106435 DOI: 10.1016/j.cytogfr.2010.10.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
20 Aden K, Tran F, Ito G, Sheibani-Tezerji R, Lipinski S, Kuiper JW, Tschurtschenthaler M, Saveljeva S, Bhattacharyya J, Häsler R, Bartsch K, Luzius A, Jentzsch M, Falk-Paulsen M, Stengel ST, Welz L, Schwarzer R, Rabe B, Barchet W, Krautwald S, Hartmann G, Pasparakis M, Blumberg RS, Schreiber S, Kaser A, Rosenstiel P. ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING. J Exp Med 2018;215:2868-86. [PMID: 30254094 DOI: 10.1084/jem.20171029] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
21 Jürgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, Wagner J, Wetzke M, Beigel F, Pfennig S, Stallhofer J. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis. Am J Gastroenterol. 2010;105:1811-1819. [PMID: 20197757 DOI: 10.1038/ajg.2010.95] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 10.0] [Reference Citation Analysis]
22 Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol. 2012;129:1438-149; 1438-149;. [PMID: 22657405 DOI: 10.1016/j.jaci.2012.05.003] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 15.0] [Reference Citation Analysis]
23 Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine Growth Factor Rev 2012;23:127-38. [PMID: 22591635 DOI: 10.1016/j.cytogfr.2012.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
24 Jung KB, Lee H, Son YS, Lee MO, Kim YD, Oh SJ, Kwon O, Cho S, Cho HS, Kim DS, Oh JH, Zilbauer M, Min JK, Jung CR, Kim J, Son MY. Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids. Nat Commun 2018;9:3039. [PMID: 30072687 DOI: 10.1038/s41467-018-05450-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 16.7] [Reference Citation Analysis]
25 Föhlinger M, Palamides P, Mansmann U, Beigel F, Siebeck M, Gropp R. Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker. J Transl Med 2016;14:310. [PMID: 27809916 DOI: 10.1186/s12967-016-1048-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
26 Das S, St Croix C, Good M, Chen J, Zhao J, Hu S, Ross M, Myerburg MM, Pilewski JM, Williams J, Wenzel SE, Kolls JK, Ray A, Ray P. Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy. iScience 2020;23:101256. [PMID: 32580124 DOI: 10.1016/j.isci.2020.101256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
27 Dulai PS, Singh S, Vande Casteele N, Boland BS, Rivera-Nieves J, Ernst PB, Eckmann L, Barrett KE, Chang JT, Sandborn WJ. Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases? Clin Gastroenterol Hepatol 2019;17:2634-43. [PMID: 31009791 DOI: 10.1016/j.cgh.2019.04.040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
28 Song B, Ma Y, Liu X, Li W, Zhang J, Liu J, Han J. IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients. Tumor Biol 2016;37:1349-56. [DOI: 10.1007/s13277-015-3916-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn’s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis. 2008;14:437-445. [PMID: 18088064 DOI: 10.1002/ibd.20339] [Cited by in Crossref: 236] [Cited by in F6Publishing: 227] [Article Influence: 18.2] [Reference Citation Analysis]
30 Gelebart P, Zak Z, Dien-Bard J, Anand M, Lai R. Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol 2011;4:9-19. [PMID: 21286373 DOI: 10.1593/tlo.10172] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
31 Rudloff I, Bachmann M, Pfeilschifter J, Mühl H. Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a. J Biol Chem 2012;287:4531-43. [PMID: 22170067 DOI: 10.1074/jbc.M111.286492] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
32 Zhou G, Yu L, Fang L, Yang W, Yu T, Miao Y, Chen M, Wu K, Chen F, Cong Y, Liu Z. CD177 + neutrophils as functionally activated neutrophils negatively regulate IBD. Gut 2018;67:1052-63. [DOI: 10.1136/gutjnl-2016-313535] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 15.0] [Reference Citation Analysis]
33 Zhao C, Chen Q, Yu S, Xu C, Li X, Zhang C, Gao L. Effect of interleukin-22 on osteogenic differentiation and the osteoclastogenic response of human periodontal ligament fibroblasts in vitro. J Periodontol 2020. [PMID: 31950496 DOI: 10.1002/JPER.19-0470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Monteleone I, Pallone F, Monteleone G. Th17-cytokine blockers as a new approach for treating inflammatory bowel disease. Ann Med 2011;43:172-8. [PMID: 21114459 DOI: 10.3109/07853890.2010.531758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
35 Jia Y, Zhang C, Hua M, Wang M, Chen P, Ma D. Aberrant NLRP3 inflammasome associated with aryl hydrocarbon receptor potentially contributes to the imbalance of T-helper cells in patients with acute myeloid leukemia. Oncol Lett 2017;14:7031-44. [PMID: 29344132 DOI: 10.3892/ol.2017.7177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ziesché E, Scheiermann P, Bachmann M, Sadik CD, Hofstetter C, Zwissler B, Pfeilschifter J, Mühl H. Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo. Clin Exp Immunol 2009;157:370-6. [PMID: 19664145 DOI: 10.1111/j.1365-2249.2009.03969.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
37 Contreras V, Urien C, Guiton R, Alexandre Y, Vu Manh TP, Andrieu T, Crozat K, Jouneau L, Bertho N, Epardaud M, Hope J, Savina A, Amigorena S, Bonneau M, Dalod M, Schwartz-Cornil I. Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol 2010;185:3313-25. [PMID: 20702727 DOI: 10.4049/jimmunol.1000824] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
38 Macdonald T, Bell I, Monteleone G. The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease. Biochemical Society Transactions 2011;39:1061-6. [DOI: 10.1042/bst0391061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
39 Bogaert S, Laukens D, Peeters H, Melis L, Olievier K, Boon N, Verbruggen G, Vandesompele J, Elewaut D, De Vos M. Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease. BMC Immunol 2010;11:61. [PMID: 21144017 DOI: 10.1186/1471-2172-11-61] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
40 Hofer U, Speck RF. Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol. 2009;31:257-266. [PMID: 19484240 DOI: 10.1007/s00281-009-0158-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
41 Bingold TM, Ziesché E, Scheller B, Sadik CD, Franck K, Just L, Sartorius S, Wahrmann M, Wissing H, Zwissler B, Pfeilschifter J, Mühl H. Interleukin-22 detected in patients with abdominal sepsis. Shock 2010;34:337-40. [PMID: 20220564 DOI: 10.1097/SHK.0b013e3181dc07b1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
42 Otte JM, Werner I, Brand S, Chromik AM, Schmitz F, Kleine M, Schmidt WE. Human beta defensin 2 promotes intestinal wound healing in vitro. J Cell Biochem 2008;104:2286-97. [PMID: 18449938 DOI: 10.1002/jcb.21787] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
43 Tan L, Rong D, Yang Y, Zhang B. Effect of Oxidized Soybean Oils on Oxidative Status and Intestinal Barrier Function in Broiler Chickens. Braz J Poult Sci 2018;20:333-42. [DOI: 10.1590/1806-9061-2017-0610] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
44 Shale M, Schiering C, Powrie F. CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev 2013;252:164-82. [PMID: 23405904 DOI: 10.1111/imr.12039] [Cited by in Crossref: 122] [Cited by in F6Publishing: 103] [Article Influence: 15.3] [Reference Citation Analysis]
45 Hu J, Li Y, Chen L, Yang Z, Zhao G, Wang Y, Cheng J, Zhao J, Peng Y. Impact of IL-22 gene polymorphism on human immunodeficiency virus infection in Han Chinese patients. J Microbiol Immunol Infect 2016;49:872-8. [PMID: 25556046 DOI: 10.1016/j.jmii.2014.09.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
46 Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 2014;13:21-38. [PMID: 24378801 DOI: 10.1038/nrd4176] [Cited by in Crossref: 337] [Cited by in F6Publishing: 302] [Article Influence: 48.1] [Reference Citation Analysis]
47 Lamarthée B, Malard F, Saas P, Mohty M, Gaugler B. Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation. Front Immunol 2016;7:148. [PMID: 27148267 DOI: 10.3389/fimmu.2016.00148] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
48 Kandasamy J, Huda S, Ambalavanan N, Jilling T. Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis. Pathophysiology 2014;21:67-80. [PMID: 24533974 DOI: 10.1016/j.pathophys.2014.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
49 Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454-467. [PMID: 18400188 DOI: 10.1016/j.immuni.2008.03.004] [Cited by in Crossref: 1165] [Cited by in F6Publishing: 1056] [Article Influence: 89.6] [Reference Citation Analysis]
50 Meisch JP, Nishimura M, Vogel RM, Sung HC, Bednarchik BA, Ghosh SK, Fu P, McCormick T, Weinberg A, Levine AD. Human β-defensin 3 peptide is increased and redistributed in Crohn's ileitis. Inflamm Bowel Dis 2013;19:942-53. [PMID: 23511030 DOI: 10.1097/MIB.0b013e318280b11a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
51 Glas J, Seiderer J, Wagner J, Olszak T, Fries C, Tillack C, Friedrich M, Beigel F, Stallhofer J, Steib C. Analysis of IL12B gene variants in inflammatory bowel disease. PLoS One. 2012;7:e34349. [PMID: 22479607 DOI: 10.1371/journal.pone.0034349] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
52 Ogawa K, Matsumoto T, Esaki M, Torisu T, Iida M. Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab. J Crohns Colitis 2012;6:529-35. [PMID: 22398057 DOI: 10.1016/j.crohns.2011.10.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
53 Garrido-mesa N, Algieri F, Rodríguez Nogales A, Gálvez J. Functional Plasticity of Th17 Cells: Implications in Gastrointestinal Tract Function. International Reviews of Immunology 2013;32:493-510. [DOI: 10.3109/08830185.2013.834899] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
54 Seillet C, Belz GT, Mielke LA. Complexity of cytokine network regulation of innate lymphoid cells in protective immunity. Cytokine 2014;70:1-10. [PMID: 24972988 DOI: 10.1016/j.cyto.2014.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
55 Sumagin R, Brazil JC, Nava P, Nishio H, Alam A, Luissint AC, Weber DA, Neish AS, Nusrat A, Parkos CA. Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing. Mucosal Immunol 2016;9:1151-62. [PMID: 26732677 DOI: 10.1038/mi.2015.135] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
56 Morales Fénero CI, Colombo Flores AA, Câmara NO. Inflammatory diseases modelling in zebrafish. World J Exp Med 2016;6:9-20. [PMID: 26929916 DOI: 10.5493/wjem.v6.i1.9] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
57 Di Martino L, Osme A, Kossak-Gupta S, Pizarro TT, Cominelli F. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Cell Mol Gastroenterol Hepatol 2019;8:427-46. [PMID: 31181286 DOI: 10.1016/j.jcmgh.2019.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Luo A, Leach ST, Barres R, Hesson LB, Grimm MC, Simar D. The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System. Front Immunol 2017;8:417. [PMID: 28443096 DOI: 10.3389/fimmu.2017.00417] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 13.8] [Reference Citation Analysis]
59 Schmitz S, Garden OA, Werling D, Allenspach K. Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease. Veterinary Immunology and Immunopathology 2012;146:87-91. [DOI: 10.1016/j.vetimm.2012.01.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
60 Yang H, de Souza Santos M, Lee J, Law HT, Chimalapati S, Verdu EF, Orth K, Vallance BA. A Novel Mouse Model of Enteric Vibrio parahaemolyticus Infection Reveals that the Type III Secretion System 2 Effector VopC Plays a Key Role in Tissue Invasion and Gastroenteritis. mBio 2019;10:e02608-19. [PMID: 31848276 DOI: 10.1128/mBio.02608-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep. 2007;9:508-512. [PMID: 18377804 DOI: 10.1007/s11894-007-0067-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
62 Seiderer J, Brand S. IL-22: a two-headed cytokine in IBD? Inflamm Bowel Dis 2009;15:473-4. [PMID: 18668680 DOI: 10.1002/ibd.20625] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
63 Dambacher J, Beigel F, Zitzmann K, Heeg MH, Göke B, Diepolder HM, Auernhammer CJ, Brand S. The role of interleukin-22 in hepatitis C virus infection. Cytokine. 2008;41:209-216. [PMID: 18191408 DOI: 10.1016/j.cyto.2007.11.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
64 Niess JH, Hruz P, Kaymak T. The Interleukin-20 Cytokines in Intestinal Diseases. Front Immunol 2018;9:1373. [PMID: 29967613 DOI: 10.3389/fimmu.2018.01373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
65 MacDonald TT, Biancheri P, Sarra M, Monteleone G. What’s the next best cytokine target in IBD? Inflamm Bowel Dis. 2012;18:2180-2189. [PMID: 22508526 DOI: 10.1002/ibd.22967] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
66 Egan CE, Cohen SB, Denkers EY. Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunol Cell Biol 2012;90:668-75. [PMID: 22064707 DOI: 10.1038/icb.2011.93] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
67 Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:701-721.e1-70. [PMID: 21377040 DOI: 10.1016/j.jaci.2010.11.050] [Cited by in Crossref: 448] [Cited by in F6Publishing: 378] [Article Influence: 44.8] [Reference Citation Analysis]
68 Weidenbusch M, Song S, Iwakura T, Shi C, Rodler S, Kobold S, Mulay SR, Honarpisheh MM, Anders HJ. IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis. Physiol Rep 2018;6:e13817. [PMID: 30156011 DOI: 10.14814/phy2.13817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
69 Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev. 2013;252:116-132. [PMID: 23405899 DOI: 10.1111/imr.12027] [Cited by in Crossref: 282] [Cited by in F6Publishing: 261] [Article Influence: 35.3] [Reference Citation Analysis]
70 Kim KO, Jang BI. Emerging Drugs in the Treatment of Inflammatory Bowel Disease: Beyond Anti-TNF-α. Korean J Gastroenterol 2011;58:235. [DOI: 10.4166/kjg.2011.58.5.235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
71 Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008;19:347-56. [PMID: 18926762 DOI: 10.1016/j.cytogfr.2008.08.003] [Cited by in Crossref: 149] [Cited by in F6Publishing: 128] [Article Influence: 11.5] [Reference Citation Analysis]
72 Storr M, Emmerdinger D, Diegelmann J, Yüce B, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S. The role of fatty acid hydrolase gene variants in inflammatory bowel disease. Aliment Pharmacol Ther 2009;29:542-51. [PMID: 19053981 DOI: 10.1111/j.1365-2036.2008.03910.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
73 Han J, Theiss AL. Stat3: friend or foe in colitis and colitis-associated cancer? Inflamm Bowel Dis. 2014;20:2405-2411. [PMID: 25185686 DOI: 10.1097/mib.0000000000000180] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
74 Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. World J Gastroenterol. 2013;19:2638-2649. [PMID: 23674871 DOI: 10.3748/wjg.v19.i17.2638] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
75 Jena G, Trivedi PP. A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches. Inflamm Bowel Dis 2014;20:553-63. [PMID: 24247651 DOI: 10.1097/01.MIB.0000436962.32164.6e] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
76 Ciccia F, Accardo-palumbo A, Alessandro R, Rizzo A, Principe S, Peralta S, Raiata F, Giardina A, De Leo G, Triolo G. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis & Rheumatism 2012;64:1869-78. [DOI: 10.1002/art.34355] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 10.6] [Reference Citation Analysis]
77 Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009;60:1647-56. [PMID: 19479869 DOI: 10.1002/art.24568] [Cited by in Crossref: 365] [Cited by in F6Publishing: 327] [Article Influence: 30.4] [Reference Citation Analysis]
78 Rae J, Hackney J, Huang K, Keir M, Herman A. Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker. Int J Mol Sci 2021;22:8205. [PMID: 34360971 DOI: 10.3390/ijms22158205] [Reference Citation Analysis]
79 Bottois H, Ngollo M, Hammoudi N, Courau T, Bonnereau J, Chardiny V, Grand C, Gergaud B, Allez M, Le Bourhis L. KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease. Front Immunol 2020;11:896. [PMID: 32477365 DOI: 10.3389/fimmu.2020.00896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
80 Yu P, Shen F, Zhang X, Cao R, Zhao X, Liu P, Tu H, Yang X, Shi R, Zhang H. Association of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population. PLoS One. 2012;7:e44380. [PMID: 22984500 DOI: 10.1371/journal.pone.0044380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
81 Weber GF, Schlautkötter S, Kaiser-Moore S, Altmayr F, Holzmann B, Weighardt H. Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun 2007;75:1690-7. [PMID: 17261606 DOI: 10.1128/IAI.01564-06] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
82 Xiao Z, Liu L, Jin Y, Pei X, Sun W, Wang M. Clostridium tyrobutyricum Protects against LPS-Induced Colonic Inflammation via IL-22 Signaling in Mice. Nutrients 2021;13:215. [PMID: 33451114 DOI: 10.3390/nu13010215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Onyiah JC, Colgan SP. Cytokine responses and epithelial function in the intestinal mucosa. Cell Mol Life Sci 2016;73:4203-12. [PMID: 27271753 DOI: 10.1007/s00018-016-2289-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
84 de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13-27. [PMID: 26627550 DOI: 10.1038/nrgastro.2015.186] [Cited by in Crossref: 612] [Cited by in F6Publishing: 510] [Article Influence: 102.0] [Reference Citation Analysis]
85 Kobold S, Völk S, Clauditz T, Küpper NJ, Minner S, Tufman A, Düwell P, Lindner M, Koch I, Heidegger S. Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J Thorac Oncol. 2013;8:1032-1042. [PMID: 23774470 DOI: 10.1097/JTO.0b013e31829923c8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 5.9] [Reference Citation Analysis]
86 Mühl H, Bachmann M. IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential. Cell Signal 2019;63:109388. [PMID: 31401146 DOI: 10.1016/j.cellsig.2019.109388] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
87 Tominaga A, Konishi Y, Taguchi T, Fukuoka S, Kawaguchi T, Noda T, Shimizu K. Autonomous cure of damaged human intestinal epithelial cells by TLR2 and TLR4-dependent production of IL-22 in response to Spirulina polysaccharides. Int Immunopharmacol 2013;17:1009-19. [PMID: 24126111 DOI: 10.1016/j.intimp.2013.09.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, Harris LD, Cervasi B, Yokomizo LK, Pan L, Vinton CL, Tabb B, Canary LA, Dang Q, Hirsch VM, Alter G, Belkaid Y, Lifson JD, Silvestri G, Milner JD, Paiardini M, Haddad EK, Brenchley JM. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 2012;5:646-57. [PMID: 22643849 DOI: 10.1038/mi.2012.38] [Cited by in Crossref: 151] [Cited by in F6Publishing: 133] [Article Influence: 16.8] [Reference Citation Analysis]
89 Cui G. TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer. Front Oncol 2019;9:1002. [PMID: 31637216 DOI: 10.3389/fonc.2019.01002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
90 Faubion WA, Fletcher JG, O'byrne S, Feagan BG, de Villiers WJ, Salzberg B, Plevy S, Proctor DD, Valentine JF, Higgins PD, Harris JM, Diehl L, Wright L, Tew GW, Luca D, Basu K, Keir ME. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging. American Journal of Gastroenterology 2013;108:1891-900. [DOI: 10.1038/ajg.2013.354] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
91 Liao Y, Peng Z, Chen L, Nüssler AK, Liu L, Yang W. Deoxynivalenol, gut microbiota and immunotoxicity: A potential approach? Food and Chemical Toxicology 2018;112:342-54. [DOI: 10.1016/j.fct.2018.01.013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
92 Ramanathan M Jr, Spannhake EW, Lane AP. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope 2007;117:1839-43. [PMID: 17906500 DOI: 10.1097/MLG.0b013e31811edd4f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
93 Gasch M, Goroll T, Bauer M, Hinz D, Schütze N, Polte T, Kesper D, Simon JC, Hackermüller J, Lehmann I. Generation of IL-8 and IL-9 producing CD4⁺ T cells is affected by Th17 polarizing conditions and AHR ligands. Mediators Inflamm. 2014;2014:182549. [PMID: 24692846 DOI: 10.1155/2014/182549] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
94 Qin S, Ma S, Huang X, Lu D, Zhou Y, Jiang H. Th22 cells are associated with hepatocellular carcinoma development and progression. Chin J Cancer Res. 2014;26:135-141. [PMID: 24826053 DOI: 10.3978/j.issn.1000-9604.2014.02.14] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
95 Zhong W, Zhao L, Liu T, Jiang Z. IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide. Sci Rep 2017;7:41143. [PMID: 28117352 DOI: 10.1038/srep41143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
96 Bernstein N, Akram M, Daniyal M, Koltai H, Fridlender M, Gorelick J. Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites. Elsevier; 2018. pp. 131-83. [DOI: 10.1016/bs.agron.2018.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
97 Pral LP, Fachi JL, Corrêa RO, Colonna M, Vinolo MAR. Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions. Trends Immunol 2021;42:604-21. [PMID: 34171295 DOI: 10.1016/j.it.2021.05.004] [Reference Citation Analysis]
98 McDermott AJ, Falkowski NR, McDonald RA, Pandit CR, Young VB, Huffnagle GB. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice. Immunology 2016;147:114-24. [PMID: 26455347 DOI: 10.1111/imm.12545] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
99 Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J, Tillack-Schreiber C, Schnitzler F, Beigel F, Brand S. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status. Inflamm Bowel Dis. 2015;21:2327-2340. [PMID: 26263469 DOI: 10.1097/mib.0000000000000515] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
100 Zheng T, Zhang B, Chen C, Ma J, Meng D, Huang J, Hu R, Liu X, Otsu K, Liu AC, Li H, Yin Z, Huang G. Protein kinase p38α signaling in dendritic cells regulates colon inflammation and tumorigenesis. Proc Natl Acad Sci U S A 2018;115:E12313-22. [PMID: 30541887 DOI: 10.1073/pnas.1814705115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
101 Zhao K, Zhao D, Huang D, Yin L, Chen C, Pan B, Wu Q, Li Z, Yao Y, Shen E, Zeng L, Xu K. Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell. J Interferon Cytokine Res 2014;34:707-15. [PMID: 24720737 DOI: 10.1089/jir.2013.0099] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
102 Gaudino SJ, Kumar P. Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis. Front Immunol 2019;10:360. [PMID: 30894857 DOI: 10.3389/fimmu.2019.00360] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 30.5] [Reference Citation Analysis]
103 Martin JC, Bériou G, Heslan M, Bossard C, Jarry A, Abidi A, Hulin P, Ménoret S, Thinard R, Anegon I, Jacqueline C, Lardeux B, Halary F, Renauld JC, Bourreille A, Josien R. IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis. Mucosal Immunol 2016;9:539-49. [PMID: 26329427 DOI: 10.1038/mi.2015.83] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
104 Meng S, Gui Q, Xu Q, Lu K, Jiao X, Fan J, Ge B, Ke Y, Zhang S, Wu J. Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation. J Mol Cell Biol. 2010;2:223-230. [PMID: 20671117 DOI: 10.1093/jmcb/mjq017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
105 Pociask DA, Scheller EV, Mandalapu S, McHugh KJ, Enelow RI, Fattman CL, Kolls JK, Alcorn JF. IL-22 is essential for lung epithelial repair following influenza infection. Am J Pathol. 2013;182:1286-1296. [PMID: 23490254 DOI: 10.1016/j.ajpath.2012.12.007] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 15.8] [Reference Citation Analysis]
106 Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10:864-871. [PMID: 19578368 DOI: 10.1038/ni.1770] [Cited by in Crossref: 677] [Cited by in F6Publishing: 625] [Article Influence: 56.4] [Reference Citation Analysis]
107 Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, Hu NW, Ma DX, Li ZF, Yang Q. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One. 2012;7:e31000. [PMID: 22485125 DOI: 10.1371/journal.pone.0031000] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 13.2] [Reference Citation Analysis]
108 Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, Godinez I, Sankaran S, Paixao TA, Gordon MA. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14:421-428. [PMID: 18376406 DOI: 10.1038/nm1743] [Cited by in Crossref: 423] [Cited by in F6Publishing: 391] [Article Influence: 32.5] [Reference Citation Analysis]
109 Katara GK, Kulshrestha A, Schneiderman S, Riehl V, Ibrahim S, Beaman KD. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer. Mol Oncol 2020;14:211-24. [PMID: 31725949 DOI: 10.1002/1878-0261.12598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
110 Brenchley JM, Silvestri G, Douek DC. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity. 2010;32:737-742. [PMID: 20620940 DOI: 10.1016/j.immuni.2010.06.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
111 Shohan M, Elahi S, Shirzad H, Rafieian-Kopaei M, Bagheri N, Soltani E. Th9 Cells: Probable players in ulcerative colitis pathogenesis. Int Rev Immunol 2018;37:192-205. [PMID: 29672174 DOI: 10.1080/08830185.2018.1457659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
112 Bassolas-Molina H, Raymond E, Labadia M, Wahle J, Ferrer-Picón E, Panzenbeck M, Zheng J, Harcken C, Hughes R, Turner M, Smith D, Calderón-Gómez E, Esteller M, Carrasco A, Esteve M, Dotti I, Corraliza AM, Masamunt MC, Arajol C, Guardiola J, Ricart E, Nabozny G, Salas A. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients. Front Immunol 2018;9:2307. [PMID: 30405600 DOI: 10.3389/fimmu.2018.02307] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
113 Ke Y, Sun D, Jiang G, Kaplan HJ, Shao H. IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol 2011;187:2130-9. [PMID: 21795593 DOI: 10.4049/jimmunol.1100482] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
114 Muls N, Nasr Z, Dang HA, Sindic C, van Pesch V. IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy. PLoS One 2017;12:e0173780. [PMID: 28301515 DOI: 10.1371/journal.pone.0173780] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
115 Nguyen PM, Putoczki TL, Ernst M. STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? J Interferon Cytokine Res. 2015;35:340-350. [PMID: 25760898 DOI: 10.1089/jir.2014.0225] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
116 Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12:383-390. [PMID: 21502992 DOI: 10.1038/ni.2025] [Cited by in Crossref: 669] [Cited by in F6Publishing: 613] [Article Influence: 66.9] [Reference Citation Analysis]
117 Monk JM, Wu W, Hutchinson AL, Pauls P, Robinson LE, Power KA. Navy and black bean supplementation attenuates colitis-associated inflammation and colonic epithelial damage. J Nutr Biochem 2018;56:215-23. [PMID: 29631142 DOI: 10.1016/j.jnutbio.2018.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
118 Marwaha AK, Leung NJ, McMurchy AN, Levings MK. TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic? Front Immunol 2012;3:129. [PMID: 22675324 DOI: 10.3389/fimmu.2012.00129] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
119 Peng Z, Tian J, Cui X, Xian W, Sun H, Li E, Geng L, Zhang L, Zhao P. Increased number of Th22 cells and correlation with Th17 cells in peripheral blood of patients with IgA nephropathy. Hum Immunol 2013;74:1586-91. [PMID: 23978338 DOI: 10.1016/j.humimm.2013.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
120 Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity. 2007;27:647-659. [PMID: 17919941 DOI: 10.1016/j.immuni.2007.07.023] [Cited by in Crossref: 472] [Cited by in F6Publishing: 460] [Article Influence: 33.7] [Reference Citation Analysis]
121 Szegedi K, Kremer AE, Kezic S, Teunissen MB, Bos JD, Luiten RM, Res PC, Middelkamp-Hup MA. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 2012;21:431-6. [PMID: 22621183 DOI: 10.1111/j.1600-0625.2012.01487.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 8.9] [Reference Citation Analysis]
122 Kim HI, Hong SH, Lee SY, Ku JM, Kim MJ, Ko SG. Gardenia Jasminoides Ameliorates Antibiotic-Associated Aggravation of DNCB-Induced Atopic Dermatitis by Restoring the Intestinal Microbiome Profile. Nutrients 2021;13:1349. [PMID: 33919521 DOI: 10.3390/nu13041349] [Reference Citation Analysis]
123 Kvedaraite E, Lourda M, Ideström M, Chen P, Olsson-Åkefeldt S, Forkel M, Gavhed D, Lindforss U, Mjösberg J, Henter JI, Svensson M. Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD. Gut 2016;65:1632-41. [PMID: 26160381 DOI: 10.1136/gutjnl-2014-309014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
124 Klatt NR, Brenchley JM. Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 2010;5:135-40. [PMID: 20543590 DOI: 10.1097/COH.0b013e3283364846] [Cited by in Crossref: 95] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
125 Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan X, Montgomery RR, Flavell RA, Town T, Fikrig E. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 2012;7:e44153. [PMID: 22952908 DOI: 10.1371/journal.pone.0044153] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
126 Beigel F, Friedrich M, Probst C, Sotlar K, Göke B, Diegelmann J, Brand S. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. PLoS One 2014;9:e93498. [PMID: 24710357 DOI: 10.1371/journal.pone.0093498] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
127 Zha JM, Li HS, Lin Q, Kuo WT, Jiang ZH, Tsai PY, Ding N, Wu J, Xu SF, Wang YT, Pan J, Zhou XM, Chen K, Tao M, Odenwald MA, Tamura A, Tsukita S, Turner JR, He WQ. Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5+ Stem Cells via Inhibition of Wnt and Notch Signaling. Cell Mol Gastroenterol Hepatol 2019;7:255-74. [PMID: 30686779 DOI: 10.1016/j.jcmgh.2018.09.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
128 Becker W, Alrafas HR, Wilson K, Miranda K, Culpepper C, Chatzistamou I, Cai G, Nagarkatti M, Nagarkatti PS. Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production. iScience 2020;23:101504. [PMID: 32942172 DOI: 10.1016/j.isci.2020.101504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
129 Aujla SJ, Kolls JK. IL-22: a critical mediator in mucosal host defense. J Mol Med (Berl). 2009;87:451-454. [PMID: 19219418 DOI: 10.1007/s00109-009-0448-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 10.1] [Reference Citation Analysis]
130 Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:180-186. [PMID: 21381156 DOI: 10.1002/ibd.21677] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 9.3] [Reference Citation Analysis]
131 Klatt NR, Harris LD, Vinton CL, Sung H, Briant JA, Tabb B, Morcock D, McGinty JW, Lifson JD, Lafont BA. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol. 2010;3:387-398. [PMID: 20357762 DOI: 10.1038/mi.2010.14] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 8.8] [Reference Citation Analysis]
132 Flamant M, Rigaill J, Paul S, Roblin X. Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects. Drugs 2017;77:1057-68. [DOI: 10.1007/s40265-017-0755-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
133 Turk HF, Monk JM, Fan YY, Callaway ES, Weeks B, Chapkin RS. Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing. Am J Physiol Cell Physiol 2013;304:C905-17. [PMID: 23426968 DOI: 10.1152/ajpcell.00379.2012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
134 Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol 2010;6:155-69. [PMID: 20383898 DOI: 10.1586/eci.09.64] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
135 Suh JS, Cho SH, Chung JH, Moon A, Park YK, Cho BS. A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy. J Interferon Cytokine Res 2013;33:571-7. [PMID: 23659670 DOI: 10.1089/jir.2012.0097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
136 Tran V, Shammas RM, Sauk JS, Padua D. Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy. Clin Exp Gastroenterol 2019;12:179-91. [PMID: 31118734 DOI: 10.2147/CEG.S150908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
137 Cosgrove C, Ussher JE, Rauch A, Gärtner K, Kurioka A, Hühn MH, Adelmann K, Kang YH, Fergusson JR, Simmonds P. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood. 2013;121:951-961. [PMID: 23255555 DOI: 10.1182/blood-2012-06-436436] [Cited by in Crossref: 219] [Cited by in F6Publishing: 197] [Article Influence: 24.3] [Reference Citation Analysis]
138 Peng Y, Gao X, Yang J, Shekhar S, Wang S, Fan Y, Zhao W, Yang X. Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection. Mol Med. 2014;20:109-119. [PMID: 24531835 DOI: 10.2119/molmed.2013.00115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
139 Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv Nutr 2020;11:77-91. [PMID: 31268137 DOI: 10.1093/advances/nmz061] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 45.0] [Reference Citation Analysis]
140 Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J. IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling. Br J Cancer. 2014;111:763-771. [PMID: 24937671 DOI: 10.1038/bjc.2014.336] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
141 Zhao L, Jiang Z, Jiang Y, Ma N, Wang K, Zhang Y, Feng L. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Exp Biol Med (Maywood). 2013;238:193-199. [PMID: 23576801 DOI: 10.1177/1535370213477597] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
142 Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin’ through a glass onion. Eur J Immunol. 2008;38:3265-3268. [PMID: 19016525 DOI: 10.1002/eji.200838655] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
143 Troncone E, Marafini I, Pallone F, Monteleone G. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. Int Rev Immunol 2013;32:526-33. [PMID: 24041379 DOI: 10.3109/08830185.2013.823421] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
144 Sekikawa A, Fukui H, Suzuki K, Karibe T, Fujii S, Ichikawa K, Tomita S, Imura J, Shiratori K, Chiba T, Fujimori T. Involvement of the IL-22/REG Ialpha axis in ulcerative colitis. Lab Invest. 2010;90:496-505. [PMID: 20065946 DOI: 10.1038/labinvest.2009.147] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
145 Kim Y, Kim TW, Park YS, Jeong EM, Lee DS, Kim IG, Chung H, Hwang YI, Lee WJ, Yu HG, Kang JS. The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis. PLoS One 2016;11:e0154904. [PMID: 27166675 DOI: 10.1371/journal.pone.0154904] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
146 Ren X, Hu B, Colletti LM. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2010;298:G74-G80. [PMID: 19875704 DOI: 10.1152/ajpgi.00075.2009] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
147 Morrison PJ, Ballantyne SJ, Kullberg MC. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology 2011;133:397-408. [PMID: 21631495 DOI: 10.1111/j.1365-2567.2011.03454.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 8.1] [Reference Citation Analysis]
148 Appiah MG, Park EJ, Darkwah S, Kawamoto E, Akama Y, Gaowa A, Kalsan M, Ahmad S, Shimaoka M. Intestinal Epithelium-Derived Luminally Released Extracellular Vesicles in Sepsis Exhibit the Ability to Suppress TNF-a and IL-17A Expression in Mucosal Inflammation. Int J Mol Sci 2020;21:E8445. [PMID: 33182773 DOI: 10.3390/ijms21228445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
149 Rees WD, Sly LM, Steiner TS. How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it! J Leukoc Biol 2020;108:309-21. [PMID: 32057139 DOI: 10.1002/JLB.3MIR0120-567R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
150 Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129:1339-1350. [PMID: 19322214 DOI: 10.1038/jid.2009.59] [Cited by in Crossref: 681] [Cited by in F6Publishing: 600] [Article Influence: 56.8] [Reference Citation Analysis]
151 Shoemaker RH, Monks A, Alley MC, Scudiero DA, Fine DL, McLemore TL, Abbott BJ, Paull KD, Mayo JG, Boyd MR. Development of human tumor cell line panels for use in disease-oriented drug screening. Prog Clin Biol Res. 1988;276:265-286. [PMID: 3051021 DOI: 10.1016/j.bcp.2012.01.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
152 Chang SH, Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine 2009;46:7-11. [PMID: 19233684 DOI: 10.1016/j.cyto.2008.12.024] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 8.6] [Reference Citation Analysis]
153 Cai T, Wang Q, Zhou Q, Wang C, Hou S, Qi J, Kijlstra A, Yang P. Increased expression of IL-22 is associated with disease activity in Behcet's disease. PLoS One 2013;8:e59009. [PMID: 23527071 DOI: 10.1371/journal.pone.0059009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
154 Muls N, Dang HA, Sindic CJ, van Pesch V. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients. PLoS One 2014;9:e113025. [PMID: 25411844 DOI: 10.1371/journal.pone.0113025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
155 Wei HX, Wang B, Li B. IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology. Front Immunol 2020;11:1315. [PMID: 32670290 DOI: 10.3389/fimmu.2020.01315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
156 Ng SC, Gazzard B. Advances in sexually transmitted infections of the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2009;6:592-607. [PMID: 19707179 DOI: 10.1038/nrgastro.2009.143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Larsen M, Arnaud L, Hié M, Parizot C, Dorgham K, Shoukry M, Kemula M, Barete S, Derai D, Sauce D, Amoura Z, Pène J, Yssel H, Gorochov G. Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol 2011;41:2596-605. [DOI: 10.1002/eji.201041131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
158 Lee Y, Kumagai Y, Jang MS, Kim JH, Yang BG, Lee EJ, Kim YM, Akira S, Jang MH. Intestinal Lin- c-Kit+ NKp46- CD4- population strongly produces IL-22 upon IL-1β stimulation. J Immunol 2013;190:5296-305. [PMID: 23589614 DOI: 10.4049/jimmunol.1201452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
159 Nady S, Abdel-Rahman M, Sousa SA, LEITãO JH, Morad M, El-Hennamy RE. Differential effects of Th17 cytokines during the response of neutrophils to Burkholderia cenocepacia outer membrane protein A. Cent Eur J Immunol 2019;44:403-13. [PMID: 32140053 DOI: 10.5114/ceji.2019.92800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Luettig J, Rosenthal R, Barmeyer C, Schulzke JD. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers 2015;3:e977176. [PMID: 25838982 DOI: 10.4161/21688370.2014.977176] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 18.3] [Reference Citation Analysis]
161 Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8:161-168. [PMID: 22288454 DOI: 10.1586/eci.11.96] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
162 Allen AJ, Park KT, Barrington GM, Lahmers KK, Abdellrazeq GS, Rihan HM, Sreevatsan S, Davies C, Hamilton MJ, Davis WC. Experimental infection of a bovine model with human isolates of Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol. 2011;141:258-266. [PMID: 21477870 DOI: 10.1016/j.vetimm.2011.03.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
163 Spekhorst LM, Visschedijk MC, Weersma RK, Festen EA. Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future. Expert Review of Clinical Immunology 2014;11:33-44. [DOI: 10.1586/1744666x.2015.990439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
164 Saeidi A, Tien Tien VL, Al-Batran R, Al-Darraji HA, Tan HY, Yong YK, Ponnampalavanar S, Barathan M, Rukumani DV, Ansari AW. Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression. PLoS One. 2015;10:e0124659. [PMID: 25894562 DOI: 10.1371/journal.pone.0124659] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
165 Ten Hove AS, Seppen J, de Jonge WJ. Neuronal innervation of the intestinal crypt. Am J Physiol Gastrointest Liver Physiol 2021;320:G193-205. [PMID: 33296267 DOI: 10.1152/ajpgi.00239.2020] [Reference Citation Analysis]
166 Brenchley JM. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol 2013;6:657-65. [PMID: 23549448 DOI: 10.1038/mi.2013.15] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
167 Jabeen R, Miller L, Yao W, Gupta S, Steiner S, Kaplan MH. Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2383-2392. [PMID: 26177303 DOI: 10.1097/mib.0000000000000495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
168 Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, Li W, Hu Y, Yu S, Qu X, Yang MX, Feng AL, Wang GH. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31:606-14. [PMID: 21556937 DOI: 10.1007/s10875-011-9540-8] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 9.8] [Reference Citation Analysis]
169 Caprioli F, Pallone F, Monteleone G. Th17 immune response in IBD: A new pathogenic mechanism. Journal of Crohn's and Colitis 2008;2:291-5. [DOI: 10.1016/j.crohns.2008.05.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
170 Bauché D, Joyce-Shaikh B, Jain R, Grein J, Ku KS, Blumenschein WM, Ganal-Vonarburg SC, Wilson DC, McClanahan TK, Malefyt RW, Macpherson AJ, Annamalai L, Yearley JH, Cua DJ. LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Immunity 2018;49:342-352.e5. [PMID: 30097293 DOI: 10.1016/j.immuni.2018.07.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 19.7] [Reference Citation Analysis]
171 Qiu Y, Jiang Z, Hu S, Wang L, Ma X, Yang X. Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli. Int J Mol Sci 2017;18:E2409. [PMID: 29137183 DOI: 10.3390/ijms18112409] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
172 Glas J, Seiderer J, Pasciuto G, Tillack C, Diegelmann J, Pfennig S, Konrad A, Schmechel S, Wetzke M, Török HP, Stallhofer J, Jürgens M, Griga T, Klein W, Epplen JT, Schiemann U, Mussack T, Lohse P, Göke B, Ochsenkühn T, Folwaczny M, Müller-Myhsok B, Brand S. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2009;104:665-72. [PMID: 19262523 DOI: 10.1038/ajg.2008.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
173 Mayuzumi H, Inagaki-Ohara K, Uyttenhove C, Okamoto Y, Matsuzaki G. Interleukin-17A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa. Immunology 2010;131:377-85. [PMID: 20575990 DOI: 10.1111/j.1365-2567.2010.03310.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
174 Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines--from host defence to tissue homeostasis. Nat Rev Immunol 2014;14:783-95. [PMID: 25421700 DOI: 10.1038/nri3766] [Cited by in Crossref: 178] [Cited by in F6Publishing: 156] [Article Influence: 29.7] [Reference Citation Analysis]
175 Mbow M, de Jong SE, Meurs L, Mboup S, Dieye TN, Polman K, Yazdanbakhsh M. Changes in immunological profile as a function of urbanization and lifestyle. Immunology 2014;143:569-77. [PMID: 24924958 DOI: 10.1111/imm.12335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
176 Coskun M, Salem M, Pedersen J, Nielsen OH. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res. 2013;76:1-8. [PMID: 23827161 DOI: 10.1016/j.phrs.2013.06.007] [Cited by in Crossref: 160] [Cited by in F6Publishing: 141] [Article Influence: 20.0] [Reference Citation Analysis]
177 Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem. 2011;353:41-46. [PMID: 21384158 DOI: 10.1007/s11010-011-0772-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
178 Aden K, Breuer A, Rehman A, Geese H, Tran F, Sommer J, Waetzig GH, Reinheimer TM, Schreiber S, Rose-John S, Scheller J, Rosenstiel P. Classic IL-6R signalling is dispensable for intestinal epithelial proliferation and repair. Oncogenesis 2016;5:e270. [PMID: 27869785 DOI: 10.1038/oncsis.2016.71] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
179 Zhen J, Yuan J, Fu Y, Zhu R, Wang M, Chang H, Zhao Y, Wang D, Lu Z. IL-22 promotes Fas expression in oligodendrocytes and inhibits FOXP3 expression in T cells by activating the NF-κB pathway in multiple sclerosis. Molecular Immunology 2017;82:84-93. [DOI: 10.1016/j.molimm.2016.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
180 He Z, Song J, Hua J, Yang M, Ma Y, Yu T, Feng J, Liu B, Wang X, Li Y, Li J. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons. Cell Death Dis 2018;9:1173. [PMID: 30518915 DOI: 10.1038/s41419-018-1223-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
181 Yu L, Wang FJ, Cui YF, Li D, Yao WR, Yang GB. Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities. Immunology 2018;154:651-62. [PMID: 29465767 DOI: 10.1111/imm.12914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
182 Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease. Inflamm Bowel Dis 2014;20:1891-901. [PMID: 25299544 DOI: 10.1097/MIB.0000000000000198] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
183 Liu J, Xu H, Zhang L, Wang S, Lu D, Chen M, Wu B. Chronoeffects of the Herbal Medicines Puerariae radix and Coptidis rhizoma in Mice: A Potential Role of REV-ERBα. Front Pharmacol 2021;12:707844. [PMID: 34393786 DOI: 10.3389/fphar.2021.707844] [Reference Citation Analysis]
184 Fukui H, Sekikawa A, Tanaka H, Fujimori Y, Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T. DMBT1 is a novel gene induced by IL-22 in ulcerative colitis. Inflamm Bowel Dis. 2011;17:1177-1188. [PMID: 20824812 DOI: 10.1002/ibd.21473] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
185 Lavoie TN, Stewart CM, Berg KM, Li Y, Nguyen CQ. Expression of interleukin-22 in Sjögren’s syndrome: significant correlation with disease parameters. Scand J Immunol. 2011;74:377-382. [PMID: 21645026 DOI: 10.1111/j.1365-3083.2011.02583.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
186 Rusmini M, Griseri P, Matera I, Pontarini E, Ravazzolo R, Mavilio D, Ceccherini I. Expression Variability and Function of the RET Gene in Adult Peripheral Blood Mononuclear Cells: RET GENE EXPRESSION IS MODULATED IN PBMCs. J Cell Physiol 2014;229:2027-37. [DOI: 10.1002/jcp.24660] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
187 Buzzeo MP, Yang J, Casella G, Reddy V. A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant 2008;17:489-94. [PMID: 18714668 DOI: 10.3727/096368908785096042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
188 Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947-957. [PMID: 19100701 DOI: 10.1016/j.immuni.2008.11] [Reference Citation Analysis]
189 Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev. 2008;226:87-102. [PMID: 19161418 DOI: 10.1111/j.1600-065x.2008.00712.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 69] [Article Influence: 13.3] [Reference Citation Analysis]
190 Wolk K, Witte E, Witte K, Warszawska K, Sabat R. Biology of interleukin-22. Semin Immunopathol. 2010;32:17-31. [PMID: 20127093 DOI: 10.1007/s00281-009-0188-x] [Cited by in Crossref: 272] [Cited by in F6Publishing: 257] [Article Influence: 24.7] [Reference Citation Analysis]
191 Bachmann M, Ulziibat S, Härdle L, Pfeilschifter J, Mühl H. IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets. Biochem Pharmacol 2013;85:396-403. [PMID: 23153456 DOI: 10.1016/j.bcp.2012.11.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
192 Shih DQ, Michelsen KS, Barrett RJ, Biener-Ramanujan E, Gonsky R, Zhang X, Targan SR. Insights into TL1A and IBD pathogenesis. Adv Exp Med Biol. 2011;691:279-288. [PMID: 21153332 DOI: 10.1007/978-1-4419-6612-4_29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
193 Gough NR, Xiang X, Mishra L. TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer. Gastroenterology 2021;161:434-452.e15. [PMID: 33940008 DOI: 10.1053/j.gastro.2021.04.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30:196-203. [PMID: 20127275 DOI: 10.1007/s10875-010-9368-7] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 12.3] [Reference Citation Analysis]
195 Maloy KJ, Kullberg MC. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol. 2008;1:339-349. [PMID: 19079198 DOI: 10.1038/mi.2008.28] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 7.5] [Reference Citation Analysis]
196 Fu SH, Lin MH, Yeh LT, Wang YL, Chien MW, Lin SH, Chang DM, Sytwu HK. Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response. Gut. 2015;64:765-775. [PMID: 25011937 DOI: 10.1136/gutjnl-2013-306585] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
197 Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity. 2012;37:601-610. [PMID: 23084357 DOI: 10.1016/j.immuni.2012] [Reference Citation Analysis]
198 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
199 Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, Park MK, Cho ML, Lee SH. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 2012;64:1015-23. [PMID: 22034096 DOI: 10.1002/art.33446] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 12.7] [Reference Citation Analysis]
200 Gálvez J. Role of Th17 Cells in the Pathogenesis of Human IBD. ISRN Inflamm. 2014;2014:928461. [PMID: 25101191 DOI: 10.1155/2014/928461] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 21.3] [Reference Citation Analysis]
201 Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn's disease. Nat Rev Gastroenterol Hepatol 2021;18:544-58. [PMID: 33712743 DOI: 10.1038/s41575-021-00424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
202 Benham H, Rehaume LM, Hasnain SZ, Velasco J, Baillet AC, Ruutu M, Kikly K, Wang R, Tseng HW, Thomas GP, Brown MA, Strutton G, McGuckin MA, Thomas R. Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol 2014;66:1755-67. [PMID: 24664521 DOI: 10.1002/art.38638] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 18.9] [Reference Citation Analysis]
203 Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E. Clinical importance of IL-22 cascade in IBD. J Gastroenterol 2018;53:465-74. [PMID: 29075900 DOI: 10.1007/s00535-017-1401-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
204 Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534-544. [PMID: 18172556 DOI: 10.1172/jci33194] [Cited by in Crossref: 142] [Cited by in F6Publishing: 416] [Article Influence: 10.9] [Reference Citation Analysis]
205 Shim EJ, Bang BR, Kang SG, Ma J, Otsuka M, Kang J, Stahl M, Han J, Xiao C, Vallance BA, Kang YJ. Activation of p38α in T cells regulates the intestinal host defense against attaching and effacing bacterial infections. J Immunol 2013;191:2764-70. [PMID: 23918973 DOI: 10.4049/jimmunol.1300908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
206 Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009;31:15-23. [PMID: 19604490 DOI: 10.1016/j.immuni.2009.06.008] [Cited by in Crossref: 225] [Cited by in F6Publishing: 213] [Article Influence: 18.8] [Reference Citation Analysis]
207 Turner JE, Stockinger B, Helmby H. IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection. PLoS Pathog. 2013;9:e1003698. [PMID: 24130494 DOI: 10.1371/journal.ppat.1003698] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 9.5] [Reference Citation Analysis]
208 Li Y, Fan L, Tang T, Tang Y, Xie M, Zeng X, Sun Y, Mei Q. Modified apple polysaccharide prevents colitis through modulating IL-22 and IL-22BP expression. International Journal of Biological Macromolecules 2017;103:1217-23. [DOI: 10.1016/j.ijbiomac.2017.05.172] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
209 Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine. 2011;56:633-640. [PMID: 21945121 DOI: 10.1016/j.cyto.2011.08.036] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 9.0] [Reference Citation Analysis]
210 Edwards JA, Tan N, Toussaint N, Ou P, Mueller C, Stanek A, Zinsou V, Roudnitsky S, Sagal M, Dresner L, Schwartzman A, Huan C. Role of regenerating islet-derived proteins in inflammatory bowel disease. World J Gastroenterol 2020;26:2702-14. [PMID: 32550748 DOI: 10.3748/wjg.v26.i21.2702] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Monk JM, Wu W, McGillis LH, Wellings HR, Hutchinson AL, Liddle DM, Graf D, Robinson LE, Power KA. Chickpea supplementation prior to colitis onset reduces inflammation in dextran sodium sulfate-treated C57Bl/6 male mice. Appl Physiol Nutr Metab 2018;43:893-901. [PMID: 29522694 DOI: 10.1139/apnm-2017-0689] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
212 Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis 2016;74:ftw111. [PMID: 27915228 DOI: 10.1093/femspd/ftw111] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 14.4] [Reference Citation Analysis]
213 Kharwar N, Prasad K, Singh K, Paliwal V, Modi D. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain–Barré syndrome. International Journal of Neuroscience 2016;127:680-7. [DOI: 10.1080/00207454.2016.1231186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
214 Zhao K, Zhao D, Huang D, Song X, Chen C, Pan B, Wu Q, Cao J, Yao Y, Zeng L, Xu K. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation. Immunobiology 2013;218:1505-13. [PMID: 23816304 DOI: 10.1016/j.imbio.2013.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
215 Bachmann M, Meissner C, Pfeilschifter J, Mühl H. Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells. Biofactors 2017;43:283-92. [PMID: 27801948 DOI: 10.1002/biof.1341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
216 Liang J, Chen P, Li C, Li D, Wang J, Xue R, Zhang S, Ruan J, Zhang X. IL-22 Down-Regulates Cx43 Expression and Decreases Gap Junctional Intercellular Communication by Activating the JNK Pathway in Psoriasis. J Invest Dermatol. 2019;139:400-411. [PMID: 30171832 DOI: 10.1016/j.jid.2018.07.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
217 Li C, Xi Y, Li S, Zhao Q, Cheng W, Wang Z, Zhong J, Niu X, Chen G. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation. Mol Immunol 2015;67:444-54. [PMID: 26224047 DOI: 10.1016/j.molimm.2015.07.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
218 Sang LX, Chang B, Zhu JF, Yang FL, Li Y, Jiang XF, Wang DN, Lu CL, Sun X. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses. World J Gastroenterol 2017;23:3850-63. [PMID: 28638225 DOI: 10.3748/wjg.v23.i21.3850] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
219 Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn’s disease. World J Gastroenterol. 2011;17:5246-5259. [PMID: 22219593 DOI: 10.3748/wjg.v17.i48.5246] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
220 Sonnenberg GF, Fouser LA, Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol. 2010;107:1-29. [PMID: 21034969 DOI: 10.1016/b978-0-12-381300-8.00001-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
221 Ryba-Stanisławowska M, Stanisławowski M, Myśliwska J. Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective. Autoimmunity 2014;47:361-71. [PMID: 24547981 DOI: 10.3109/08916934.2014.886198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
222 Patterson AM, Watson AJM. Deciphering the Complex Signaling Systems That Regulate Intestinal Epithelial Cell Death Processes and Shedding. Front Immunol 2017;8:841. [PMID: 28769935 DOI: 10.3389/fimmu.2017.00841] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
223 Toedter G, Li K, Marano C, Ma K, Sague S, Huang CC, Song XY, Rutgeerts P, Baribaud F. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Am J Gastroenterol. 2011;106:1272-1280. [PMID: 21448149 DOI: 10.1038/ajg.2011.83] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.5] [Reference Citation Analysis]
224 Zhao L, Jiang Z, Jiang Y, Ma N, Zhang Y, Feng L, Wang K. IL-22+ CD4+ T cells in patients with rheumatoid arthritis. Int J Rheum Dis 2013;16:518-26. [PMID: 24164838 DOI: 10.1111/1756-185X.12099] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 3.9] [Reference Citation Analysis]
225 Eidenschenk C, Rutz S, Liesenfeld O, Ouyang W. Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol 2014;380:213-36. [PMID: 25004820 DOI: 10.1007/978-3-662-43492-5_10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
226 Ahlfors H, Morrison PJ, Duarte JH, Li Y, Biro J, Tolaini M, Di Meglio P, Potocnik AJ, Stockinger B. IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J Immunol 2014;193:4602-13. [PMID: 25261485 DOI: 10.4049/jimmunol.1401244] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 10.0] [Reference Citation Analysis]
227 Hanyang L, Xuanzhe L, Xuyang C, Yujia Q, Jiarong F, Jun S, Zhihua R. Application of Zebrafish Models in Inflammatory Bowel Disease. Front Immunol 2017;8:501. [PMID: 28515725 DOI: 10.3389/fimmu.2017.00501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
228 Smith CL, Arvedson TL, Cooke KS, Dickmann LJ, Forte C, Li H, Merriam KL, Perry VK, Tran L, Rottman JB, Maxwell JR. IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol 2013;191:1845-55. [PMID: 23836059 DOI: 10.4049/jimmunol.1202716] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
229 Peng D, Xu B, Wang Y, Guo H, Jiang Y. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease. PLoS One 2013;8:e68446. [PMID: 23874630 DOI: 10.1371/journal.pone.0068446] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
230 Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8:161-168. [PMID: 22288454 DOI: 10.1586/eci.11.96.] [Reference Citation Analysis]
231 Reichhardt M, Holmskov U, Meri S. SALSA—A dance on a slippery floor with changing partners. Molecular Immunology 2017;89:100-10. [DOI: 10.1016/j.molimm.2017.05.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
232 Mühl H, Scheiermann P, Bachmann M, Härdle L, Heinrichs A, Pfeilschifter J. IL-22 in tissue-protective therapy. Br J Pharmacol. 2013;169:761-771. [PMID: 23530726 DOI: 10.1111/bph.12196] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
233 Rudloff I, Jardé T, Bachmann M, Elgass KD, Kerr G, Engel R, Richards E, Oliva K, Wilkins S, Mcmurrick PJ, Abud HE, Mühl H, Nold MF. Molecular signature of interleukin-22 in colon carcinoma cells and organoid models. Translational Research 2020;216:1-22. [DOI: 10.1016/j.trsl.2019.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
234 Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W, Chaplin DD, Weaver CT. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA. 2013;110:12768-12773. [PMID: 23781104 DOI: 10.1073/pnas.1300318110] [Cited by in Crossref: 215] [Cited by in F6Publishing: 196] [Article Influence: 26.9] [Reference Citation Analysis]
235 Spalinger MR, Kasper S, Chassard C, Raselli T, Frey-Wagner I, Gottier C, Lang S, Atrott K, Vavricka SR, Mair F. PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 2015;8:918-929. [PMID: 25492475 DOI: 10.1038/mi.2014.122] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
236 Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013;210:917-931. [PMID: 23589566 DOI: 10.1084/jem.20122308] [Cited by in Crossref: 351] [Cited by in F6Publishing: 309] [Article Influence: 43.9] [Reference Citation Analysis]
237 McLean MH, Neurath MF, Durum SK. Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy? Inflamm Bowel Dis. 2014;20:389-397. [PMID: 24356385 DOI: 10.1097/01.mib.0000437616.37000.41] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
238 Mühl H. Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? Front Immunol. 2013;4:18. [PMID: 23382730 DOI: 10.3389/fimmu.2013.00018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
239 Li A, Gan Y, Wang R, Liu Y, Ma T, Huang M, Cui X. IL-22 Up-Regulates β-Defensin-2 Expression in Human Alveolar Epithelium via STAT3 but Not NF-κB Signaling Pathway. Inflammation 2015;38:1191-200. [PMID: 25510212 DOI: 10.1007/s10753-014-0083-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
240 Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012;491:259-63. [PMID: 23075849 DOI: 10.1038/nature11535] [Cited by in Crossref: 466] [Cited by in F6Publishing: 407] [Article Influence: 51.8] [Reference Citation Analysis]
241 Eken A, Singh AK, Oukka M. Interleukin 23 in Crohn's disease. Inflamm Bowel Dis 2014;20:587-95. [PMID: 24481050 DOI: 10.1097/01.MIB.0000442014.52661.20] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 3.9] [Reference Citation Analysis]
242 Hernandez P, Gronke K, Diefenbach A. A catch-22: Interleukin-22 and cancer. Eur J Immunol 2018;48:15-31. [DOI: 10.1002/eji.201747183] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
243 Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 2013;6:177-188. [PMID: 22854708 DOI: 10.1038/mi.2012.61] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 9.0] [Reference Citation Analysis]
244 Yu ZQ, Wang WF, Dai YC, Chen XC, Chen JY. Interleukin-22 receptor 1 is expressed in multinucleated giant cells: A study on intestinal tuberculosis and Crohn's disease. World J Gastroenterol 2019;25:2473-88. [PMID: 31171891 DOI: 10.3748/wjg.v25.i20.2473] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
245 Shuttleworth S, Townsend P, Silva F, Cecil A, Hill T, Tomassi C, Rogers H, Harrison R. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases. Prog Med Chem 2011;50:109-33. [PMID: 21315929 DOI: 10.1016/B978-0-12-381290-2.00003-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
246 Tack GJ, van Wanrooij RL, Von Blomberg BM, Amini H, Coupe VM, Bonnet P, Mulder CJ, Schreurs MW. Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study. BMC Gastroenterol 2012;12:159. [PMID: 23145841 DOI: 10.1186/1471-230X-12-159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
247 Brandner JM, Schulzke JD. Hereditary barrier-related diseases involving the tight junction: lessons from skin and intestine. Cell Tissue Res 2015;360:723-48. [DOI: 10.1007/s00441-014-2096-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
248 Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 2013;8:477-512. [PMID: 23157335 DOI: 10.1146/annurev-pathol-011110-130318] [Cited by in Crossref: 264] [Cited by in F6Publishing: 233] [Article Influence: 29.3] [Reference Citation Analysis]
249 Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947-957. [PMID: 19100701 DOI: 10.1016/j.immuni.2008.11.003] [Cited by in Crossref: 568] [Cited by in F6Publishing: 538] [Article Influence: 47.3] [Reference Citation Analysis]
250 Manni ML, Alcorn JF. The enigmatic role of IL-22 in asthma. Expert Rev Respir Med 2016;10:619-23. [PMID: 27043459 DOI: 10.1080/17476348.2016.1174580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
251 Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ. The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis 2011;2011:810649. [PMID: 22164330 DOI: 10.1155/2011/810649] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
252 Hölttä V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho KL, Vaarala O. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;57:287-292. [PMID: 23974060 DOI: 10.1097/mpg.0b013e3182979252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
253 Liu Y, Pan W, Yang S, Wu X, Wu J, Ma J, Yuan Z, Meng S. Interleukin-22 protects rat PC12 pheochromocytoma cells from serum deprivation-induced cell death. Mol Cell Biochem 2012;371:137-46. [DOI: 10.1007/s11010-012-1430-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
254 Jiang Q, Yang G, Xiao F, Xie J, Wang S, Lu L, Cui D. Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases. Front Immunol 2021;12:688066. [PMID: 34295334 DOI: 10.3389/fimmu.2021.688066] [Reference Citation Analysis]
255 Jia L, Wu C. The biology and functions of Th22 cells. Adv Exp Med Biol 2014;841:209-30. [PMID: 25261209 DOI: 10.1007/978-94-017-9487-9_8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 8.8] [Reference Citation Analysis]
256 Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, Spits H. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010;33:752-64. [PMID: 21055975 DOI: 10.1016/j.immuni.2010.10.012] [Cited by in Crossref: 180] [Cited by in F6Publishing: 176] [Article Influence: 16.4] [Reference Citation Analysis]
257 Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis. 2012;18:1777-1784. [PMID: 22359410 DOI: 10.1002/ibd.22929] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 9.2] [Reference Citation Analysis]
258 Hao C, Wang J, Kang W, Xie Y, Zhou Y, Ma L, Peng M, Bai X, Lian J, Jia Z. Kinetics of Th17 Cytokines During Telbivudine Therapy in Patients With Chronic Hepatitis B. Viral Immunology 2013;26:336-42. [DOI: 10.1089/vim.2013.0032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
259 Hruz P, Dann SM, Eckmann L. STAT3 and its activators in intestinal defense and mucosal homeostasis. Curr Opin Gastroenterol. 2010;26:109-115. [PMID: 20040863 DOI: 10.1097/mog.0b013e3283365279] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
260 Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282-9. [DOI: 10.1038/nm1720] [Cited by in Crossref: 1292] [Cited by in F6Publishing: 1204] [Article Influence: 99.4] [Reference Citation Analysis]
261 Friedrich M, Diegelmann J, Schauber J, Auernhammer CJ, Brand S. Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. Mucosal Immunol 2015;8:943-58. [PMID: 25492478 DOI: 10.1038/mi.2014.124] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
262 Chen Y, Vandereyken M, Newton IP, Moraga I, Näthke IS, Swamy M. Loss of adenomatous polyposis coli function renders intestinal epithelial cells resistant to the cytokine IL-22. PLoS Biol 2019;17:e3000540. [PMID: 31770366 DOI: 10.1371/journal.pbio.3000540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Monteleone I, Pallone F, Monteleone G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med 2011;9:122. [PMID: 22082127 DOI: 10.1186/1741-7015-9-122] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
264 Nussenblatt RB. * Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis. Uveitis. Elsevier; 2010. pp. 1-36. [DOI: 10.1016/b978-1-4377-0667-3.00006-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
265 Kang SS, Bloom SM, Norian LA, Geske MJ, Flavell RA, Stappenbeck TS, Allen PM. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 2008;5:e41. [PMID: 18318596 DOI: 10.1371/journal.pmed.0050041] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 7.2] [Reference Citation Analysis]
266 Church LD, Filer AD, Hidalgo E, Howlett KA, Thomas AM, Rapecki S, Scheel-Toellner D, Buckley CD, Raza K. Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression. Arthritis Res Ther 2010;12:R184. [PMID: 20929536 DOI: 10.1186/ar3152] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
267 Song X, Gao H, Qian Y. Th17 differentiation and their pro-inflammation function. Adv Exp Med Biol. 2014;841:99-151. [PMID: 25261206 DOI: 10.1007/978-94-017-9487-9_5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
268 Li S, Peppelenbosch MP, Smits R. Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019;1872:74-9. [DOI: 10.1016/j.bbcan.2019.05.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
269 Marquet S, Conte I, Poudiougou B, Argiro L, Dessein H, Couturier C, Burté F, Oumar AA, Brown BJ, Traore A, Afolabi NK, Barry A, Omokhodion S, Shokunbi WA, Sodeinde O, Doumbo O, Fernandez-Reyes D, Dessein AJ. A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria. Sci Rep 2017;7:41636. [PMID: 28139719 DOI: 10.1038/srep41636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
270 Lim C, Hong M, Savan R. Human IL-22 binding protein isoforms act as a rheostat for IL-22 signaling. Sci Signal 2016;9:ra95-ra95. [DOI: 10.1126/scisignal.aad9887] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
271 Wang Y, Zhu H, Wang X, Yu Y, Xie J. Natural Food Polysaccharides Ameliorate Inflammatory Bowel Disease and Its Mechanisms. Foods 2021;10:1288. [PMID: 34199820 DOI: 10.3390/foods10061288] [Reference Citation Analysis]
272 Lai LJ, Shen J, Ran ZH. Natural killer T cells and ulcerative colitis. Cell Immunol 2019;335:1-5. [PMID: 30638678 DOI: 10.1016/j.cellimm.2018.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
273 Akbari H, Asadikaram G, Jafari A, Nazari-robati M, Ebrahimi G, Ebrahimi N, Masoumi M. Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease; the role of gene polymorphism. Life Sciences 2018;207:525-31. [DOI: 10.1016/j.lfs.2018.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
274 Zhong X, Kieras E, Sousa E, D'Antona A, Baber JC, He T, Desharnais J, Wood L, Luxenberg D, Stahl M, Kriz R, Lin L, Somers W, Fitz LJ, Wright JF. Pyroglutamate and O-linked glycan determine functional production of anti-IL17A and anti-IL22 peptide-antibody bispecific genetic fusions. J Biol Chem 2013;288:1409-19. [PMID: 23184956 DOI: 10.1074/jbc.M112.417717] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
275 Glas J, Seiderer J, Nagy M, Fries C, Beigel F, Weidinger M, Pfennig S, Klein W, Epplen JT, Lohse P. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. PLoS One. 2010;5:e10373. [PMID: 20454450 DOI: 10.1371/journal.pone.0010373] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
276 Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH. High Suppressor of Cytokine Signaling-3 Expression Impairs STAT3-dependent Protective Effects of Interleukin-22 in Ulcerative Colitis in Remission: . Inflammatory Bowel Diseases 2015;21:241-50. [DOI: 10.1097/mib.0000000000000267] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
277 Witte E, Witte K, Warszawska K, Sabat R, Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 2010;21:365-79. [PMID: 20870448 DOI: 10.1016/j.cytogfr.2010.08.002] [Cited by in Crossref: 161] [Cited by in F6Publishing: 153] [Article Influence: 14.6] [Reference Citation Analysis]
278 Endam LM, Bossé Y, Filali-mouhim A, Cormier C, Boisvert P, Boulet L, Hudson TJ, Desrosiers M. Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009;140:741-7. [DOI: 10.1016/j.otohns.2008.12.058] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
279 Lim C, Savan R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev. 2014;25:257-271. [PMID: 24856143 DOI: 10.1016/j.cytogfr.2014.04.005] [Cited by in Crossref: 95] [Cited by in F6Publishing: 78] [Article Influence: 13.6] [Reference Citation Analysis]
280 Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, Maier K, Griga T, Klein W, Epplen JT, Schiemann U, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Folwaczny M, Mussack T, Brand S. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2007;2:e819. [PMID: 17786191 DOI: 10.1371/journal.pone.0000819] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 6.9] [Reference Citation Analysis]
281 Li S, Yu M, Li H, Zhang H, Jiang Y. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators Inflamm 2012;2012:260473. [PMID: 23091305 DOI: 10.1155/2012/260473] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
282 Monteleone I, Pallone F, Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm. 2009;2009:297645. [PMID: 19503799 DOI: 10.1155/2009/297654] [Reference Citation Analysis]
283 Ma SD, Lancto CA, Enomoto S, Abrahamsen MS, Rutherford MS. Expression and regulation of IL-22 by bovine peripheral blood gamma/delta T cells. Gene 2010;451:6-14. [PMID: 19879340 DOI: 10.1016/j.gene.2009.08.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
284 Shaler CR, Elhenawy W, Coombes BK. The Unique Lifestyle of Crohn's Disease-Associated Adherent-Invasive Escherichia coli. J Mol Biol 2019;431:2970-81. [PMID: 31029703 DOI: 10.1016/j.jmb.2019.04.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
285 Cray P, Sheahan BJ, Dekaney CM. Secretory Sorcery: Paneth Cell Control of Intestinal Repair and Homeostasis. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00121-1. [PMID: 34153524 DOI: 10.1016/j.jcmgh.2021.06.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Franz J, Jerome J, Lear T, Gong Q, Weathington NM. The Human IL-22 Receptor Is Regulated through the Action of the Novel E3 Ligase Subunit FBXW12, Which Functions as an Epithelial Growth Suppressor. J Immunol Res 2015;2015:912713. [PMID: 26171402 DOI: 10.1155/2015/912713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
287 Yu S, Liu C, Zhang L, Shan B, Tian T, Hu Y, Shao L, Sun Y, Ji C, Ma D. Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia. Int J Mol Sci 2014;15:1927-45. [PMID: 24473142 DOI: 10.3390/ijms15021927] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
288 Kaemmerer E, Kuhn P, Schneider U, Jeon MK, Klaus C, Schiffer M, Weisner D, Liedtke C, Jäkel J, Kennes LN, Hilgers RD, Wagner N, Gassler N. Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes. World J Gastroenterol 2015;21:4499-508. [PMID: 25914458 DOI: 10.3748/wjg.v21.i15.4499] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
289 Martin JC, Bériou G, Heslan M, Chauvin C, Utriainen L, Aumeunier A, Scott CL, Mowat A, Cerovic V, Houston SA, Leboeuf M, Hubert FX, Hémont C, Merad M, Milling S, Josien R. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol 2014;7:101-13. [PMID: 23653115 DOI: 10.1038/mi.2013.28] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 12.1] [Reference Citation Analysis]
290 Spalinger MR, Sayoc-Becerra A, Ordookhanian C, Canale V, Santos AN, King SJ, Krishnan M, Nair MG, Scharl M, McCole DF. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. J Crohns Colitis 2021;15:471-84. [PMID: 32909045 DOI: 10.1093/ecco-jcc/jjaa182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
291 Stockinger B, Veldhoen M, Martin B. Th17 T cells: linking innate and adaptive immunity. Semin Immunol. 2007;19:353-361. [PMID: 18023589 DOI: 10.1016/j.smim.2007.10.008] [Cited by in Crossref: 182] [Cited by in F6Publishing: 176] [Article Influence: 13.0] [Reference Citation Analysis]
292 Ness-Schwickerath KJ, Jin C, Morita CT. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol. 2010;184:7268-7280. [PMID: 20483730 DOI: 10.4049/jimmunol.1000600] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 12.0] [Reference Citation Analysis]
293 Galien R. Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes. Pharmacological Reports 2016;68:789-96. [DOI: 10.1016/j.pharep.2016.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
294 Glal D, Sudhakar JN, Lu HH, Liu MC, Chiang HY, Liu YC, Cheng CF, Shui JW. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol 2018;9:2522. [PMID: 30455690 DOI: 10.3389/fimmu.2018.02522] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
295 Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, Sher A, Grigg M, Collins M, Fouser L, Wynn TA. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 2010;184:4378-90. [PMID: 20220096 DOI: 10.4049/jimmunol.0903416] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 9.5] [Reference Citation Analysis]
296 Diegelmann J, Czamara D, Le Bras E, Zimmermann E, Olszak T, Bedynek A, Göke B, Franke A, Glas J, Brand S. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2. PLoS One 2013;8:e77773. [PMID: 24223725 DOI: 10.1371/journal.pone.0077773] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
297 Ouyang W, Valdez P. IL-22 in mucosal immunity. Mucosal Immunol. 2008;1:335-338. [PMID: 19079197 DOI: 10.1038/mi.2008.26] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
298 Zwarycz B, Gracz AD, Rivera KR, Williamson IA, Samsa LA, Starmer J, Daniele MA, Salter-Cid L, Zhao Q, Magness ST. IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model. Cell Mol Gastroenterol Hepatol 2019;7:1-17. [PMID: 30364840 DOI: 10.1016/j.jcmgh.2018.06.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
299 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
300 Young RS, Wiles BM, McGee DW. IL-22 Enhances TNF-α- and IL-1-Induced CXCL8 Responses by Intestinal Epithelial Cell Lines. Inflammation 2017;40:1726-34. [PMID: 28656529 DOI: 10.1007/s10753-017-0614-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
301 Su SB, Qin SY, Xian XL, Huang FF, Huang QL, ZhangDi HJ, Jiang HX. Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis. Life Sci 2021;264:118677. [PMID: 33129875 DOI: 10.1016/j.lfs.2020.118677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn’s disease. Am J Gastroenterol. 2009;104:1723-1733. [PMID: 19455129 DOI: 10.1038/ajg.2009.184] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
303 de Moura PR, Watanabe L, Bleicher L, Colau D, Dumoutier L, Lemaire MM, Renauld JC, Polikarpov I. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22. FEBS Lett. 2009;583:1072-1077. [PMID: 19285080 DOI: 10.1016/j.febslet.2009.03.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
304 Jernås M, Hou Y, Strömberg Célind F, Shao L, Wang Q, Ju X, Mellgren K, Wadenvik H, Hou M, Olsson B. Altered cytokine levels in pediatric ITP. Platelets 2015;26:589-92. [PMID: 25806433 DOI: 10.3109/09537104.2014.974526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
305 Diegelmann J, Olszak T, Göke B, Blumberg RS, Brand S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem. 2012;287:286-298. [PMID: 22069308 DOI: 10.1074/jbc.M111.294355] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
306 Jürgens M, Brand S, Laubender RP, Seiderer J, Glas J, Wetzke M, Wagner J, Pfennig S, Tillack C, Beigel F. The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype. J Gastroenterol. 2010;45:721-731. [PMID: 20428899 DOI: 10.1007/s00535-010-0231-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
307 Walter MR. The Role of Structure in the Biology of Interferon Signaling. Front Immunol 2020;11:606489. [PMID: 33281831 DOI: 10.3389/fimmu.2020.606489] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
308 Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity. 2012;37:601-610. [PMID: 23084357 DOI: 10.1016/j.immuni.2012.10.003] [Cited by in Crossref: 181] [Cited by in F6Publishing: 157] [Article Influence: 20.1] [Reference Citation Analysis]
309 Akiho H, Ihara E, Motomura Y, Nakamura K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol. 2011;2:72-81. [PMID: 22013552 DOI: 10.4291/wjgp.v2.i5.72] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
310 Thompson JS, Chu Y, Glass JF, Brown SA. Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. Bone Marrow Transplant 2010;45:712-22. [PMID: 19718070 DOI: 10.1038/bmt.2009.215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
311 Endharti AT, Wulandari A, Listyana A, Norahmawati E, Permana S. Dendrophthoe pentandra (L.) Miq extract effectively inhibits inflammation, proliferation and induces p53 expression on colitis-associated colon cancer. BMC Complement Altern Med 2016;16:374. [PMID: 27670445 DOI: 10.1186/s12906-016-1345-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
312 Irwin R, Raehtz S, Parameswaran N, McCabe LR. Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol 2016;311:R1149-57. [PMID: 27733383 DOI: 10.1152/ajpregu.00051.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
313 Tian T, Yu S, Ma D. Th22 and related cytokines in inflammatory and autoimmune diseases. Expert Opin Ther Targets. 2013;17:113-125. [PMID: 23256771 DOI: 10.1517/14728222.2013.736497] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
314 van der Gracht E, Zahner S, Kronenberg M. When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators Inflamm 2016;2016:9765238. [PMID: 27578924 DOI: 10.1155/2016/9765238] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
315 Chestovich PJ, Uchida Y, Chang W, Ajalat M, Lassman C, Sabat R, Busuttil RW, Kupiec-Weglinski JW. Interleukin-22: implications for liver ischemia-reperfusion injury. Transplantation 2012;93:485-92. [PMID: 22262131 DOI: 10.1097/TP.0b013e3182449136] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
316 Yang Y, Tomkovich S, Jobin C. Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish. Inflamm Bowel Dis 2014;20:956-66. [PMID: 24577115 DOI: 10.1097/01.MIB.0000442923.85569.68] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
317 Parhar K, Morse J, Salh B. The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling. Int J Colorectal Dis 2007;22:601-9. [PMID: 17009010 DOI: 10.1007/s00384-006-0193-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
318 Glas J, Seiderer J, Bayrle C, Wetzke M, Fries C, Tillack C, Olszak T, Beigel F, Steib C, Friedrich M, Diegelmann J, Czamara D, Brand S. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PLoS One 2011;6:e29309. [PMID: 22242114 DOI: 10.1371/journal.pone.0029309] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
319 Gunasekera DC, Ma J, Vacharathit V, Shah P, Ramakrishnan A, Uprety P, Shen Z, Sheh A, Brayton CF, Whary MT, Fox JG, Bream JH. The development of colitis in Il10-/- mice is dependent on IL-22. Mucosal Immunol 2020;13:493-506. [PMID: 31932715 DOI: 10.1038/s41385-019-0252-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
320 Tian Z, van Velkinburgh JC, Wu Y, Ni B. Innate lymphoid cells involve in tumorigenesis: Effects of ILCs on tumorigenesis. Int J Cancer 2016;138:22-9. [DOI: 10.1002/ijc.29443] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
321 Moon SY, Kim KD, Yoo J, Lee JH, Hwangbo C. Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models. Molecules 2021;26:2824. [PMID: 34068714 DOI: 10.3390/molecules26092824] [Reference Citation Analysis]
322 Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn’s disease. World J Gastroenterol. 2012;18:105-118. [PMID: 22253516 DOI: 10.3748/wjg.v18.i2.105] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
323 Wei P, Hu GH, Kang HY, Yao HB, Kou W, Liu H, Hong SL. Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis. QJM 2014;107:107-13. [PMID: 24049053 DOI: 10.1093/qjmed/hct188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
324 Murdoch CC, Rawls JF. Commensal Microbiota Regulate Vertebrate Innate Immunity-Insights From the Zebrafish. Front Immunol 2019;10:2100. [PMID: 31555292 DOI: 10.3389/fimmu.2019.02100] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
325 Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol. 2013;182:21-28. [PMID: 23159948 DOI: 10.1016/j.ajpath.2012.08.043] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
326 Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, Soleimanifar N, Zavvar M, Nicknam MH. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 2018;100:198-204. [DOI: 10.1016/j.biopha.2018.01.108] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
327 Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn’s disease in the German population. Am J Gastroenterol. 2008;103:682-691. [PMID: 18162085 DOI: 10.1111/j.1572-0241.2007.01694.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 5.2] [Reference Citation Analysis]
328 Hu Y, Li H, Zhang L, Shan B, Xu X, Li H, Liu X, Xu S, Yu S, Ma D. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hum Immunol. 2012;73:629-635. [PMID: 22537755 DOI: 10.1016/j.humimm.2012.04.015] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
329 Matthews JD, Weight CM, Parkos CA. Leukocyte-epithelial interactions and mucosal homeostasis. Toxicol Pathol. 2014;42:91-98. [PMID: 24285670 DOI: 10.1177/0192623313511336] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
330 Charrier-Hisamuddin L, Laboisse CL, Merlin D. ADAM-15: a metalloprotease that mediates inflammation. FASEB J 2008;22:641-53. [PMID: 17905725 DOI: 10.1096/fj.07-8876rev] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
331 Lu T, Liu Y, Li P, Yu S, Huang X, Ma D, Ji C. Decreased circulating Th22 and Th17 cells in patients with aplastic anemia. Clin Chim Acta 2015;450:90-6. [PMID: 26238188 DOI: 10.1016/j.cca.2015.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
332 Geremia A, Jewell DP. The IL-23/IL-17 pathway in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2012;6:223-237. [PMID: 22375527 DOI: 10.1586/egh.11.107] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
333 Cayatte C, Joyce-Shaikh B, Vega F, Boniface K, Grein J, Murphy E, Blumenschein WM, Chen S, Malinao MC, Basham B. Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2012;3:e10. [PMID: 23238132 DOI: 10.1038/ctg.2012.2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
334 Lenaerts K, Bouwman FG, Lamers WH, Renes J, Mariman EC. Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics. 2007;8:91. [PMID: 17407598 DOI: 10.1186/1471-2164-8-91] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
335 Bhaumik S, Basu R. Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response. Front Immunol 2017;8:254. [PMID: 28408906 DOI: 10.3389/fimmu.2017.00254] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
336 Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206:1465-1472. [PMID: 19564350 DOI: 10.1084/jem.20082683] [Cited by in Crossref: 661] [Cited by in F6Publishing: 612] [Article Influence: 55.1] [Reference Citation Analysis]
337 Qiu J, Zhou L. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation. Semin Immunopathol 2013;35:657-70. [PMID: 23975386 DOI: 10.1007/s00281-013-0393-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
338 Wang L, Xie H, Xu L, Liao Q, Wan S, Yu Z, Lin D, Zhang B, Lv Z, Wu Z, Sun X. rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway. Theranostics 2017;7:3446-60. [PMID: 28912887 DOI: 10.7150/thno.20359] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
339 Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. [PMID: 18297430 DOI: 10.1007/s00535-007-2111-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 8.9] [Reference Citation Analysis]
340 Sziksz E, Pap D, Lippai R, Béres NJ, Fekete A, Szabó AJ, Vannay Á. Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family. Mediators Inflamm 2015;2015:764641. [PMID: 26199463 DOI: 10.1155/2015/764641] [Cited by in Crossref: 132] [Cited by in F6Publishing: 116] [Article Influence: 22.0] [Reference Citation Analysis]
341 Friedrich M, Diegelmann J, Beigel F, Brand S. IL-17A Alone Weakly Affects the Transcriptome of Intestinal Epithelial Cells but Strongly Modulates the TNF-α–induced Expression of Inflammatory Mediators and Inflammatory Bowel Disease Susceptibility Genes: . Inflammatory Bowel Diseases 2014;20:1502-15. [DOI: 10.1097/mib.0000000000000121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
342 Sarra M, Pallone F, Macdonald TT, Monteleone G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis. 2010;16:1808-1813. [PMID: 20222127 DOI: 10.1002/ibd.21248] [Cited by in Crossref: 177] [Cited by in F6Publishing: 168] [Article Influence: 17.7] [Reference Citation Analysis]
343 Xue X, Falcon DM. The Role of Immune Cells and Cytokines in Intestinal Wound Healing. Int J Mol Sci 2019;20:E6097. [PMID: 31816903 DOI: 10.3390/ijms20236097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
344 Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol. 2008;14:348-353. [PMID: 18200658 DOI: 10.3748/wjg.14.348] [Cited by in CrossRef: 206] [Cited by in F6Publishing: 189] [Article Influence: 15.8] [Reference Citation Analysis]
345 Lee Y, Collins M, Kuchroo VK. Unexpected targets and triggers of autoimmunity. J Clin Immunol 2014;34 Suppl 1:S56-60. [PMID: 24789684 DOI: 10.1007/s10875-014-0040-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
346 Park JH, Peyrin-Biroulet L, Eisenhut M, Shin JI. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Autoimmun Rev. 2017;16:416-426. [PMID: 28212924 DOI: 10.1016/j.autrev.2017.02.013] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 30.3] [Reference Citation Analysis]
347 Mortazavi-jahromi SS, Nazeri S, Jafarnezhad-ansariha F, Oraei M, Mirshafiey A. Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties. Immunol Res 2019;67:108-15. [DOI: 10.1007/s12026-018-9042-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
348 Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B, Brand S. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis 2008;14:204-12. [PMID: 18022867 DOI: 10.1002/ibd.20315] [Cited by in Crossref: 133] [Cited by in F6Publishing: 130] [Article Influence: 10.2] [Reference Citation Analysis]
349 Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009;104:1737-44. [PMID: 19455118 DOI: 10.1038/ajg.2009.163] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
350 Wang Y, Mumm JB, Herbst R, Kolbeck R, Wang Y. IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression. J Immunol 2017;199:3316-25. [PMID: 28939759 DOI: 10.4049/jimmunol.1700152] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
351 Knight JS, Baird DB, Hein WR, Pernthaner A. The gastrointestinal nematode Trichostrongylus colubriformis down-regulates immune gene expression in migratory cells in afferent lymph. BMC Immunol 2010;11:51. [PMID: 20950493 DOI: 10.1186/1471-2172-11-51] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
352 Zhang YM, Liu ZR, Cui ZL, Yang C, Yang L, Li Y, Shen ZY. Interleukin-22 contributes to liver regeneration in mice with concanavalin A-induced hepatitis after hepatectomy. World J Gastroenterol. 2016;22:2081-2091. [PMID: 26877612 DOI: 10.3748/wjg.v22.i6.2081] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
353 Kempski J, Giannou AD, Riecken K, Zhao L, Steglich B, Lücke J, Garcia-Perez L, Karstens KF, Wöstemeier A, Nawrocki M, Pelczar P, Witkowski M, Nilsson S, Konczalla L, Shiri AM, Kempska J, Wahib R, Brockmann L, Huber P, Gnirck AC, Turner JE, Zazara DE, Arck PC, Stein A, Simon R, Daubmann A, Meiners J, Perez D, Strowig T, Koni P, Kruglov AA, Sauter G, Izbicki JR, Guse AH, Rösch T, Lohse AW, Flavell RA, Gagliani N, Huber S. IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans. Gastroenterology 2020;159:1417-1430.e3. [PMID: 32585307 DOI: 10.1053/j.gastro.2020.06.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
354 Wu W, Chen F, Liu Z, Cong Y. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1473-82. [PMID: 27057688 DOI: 10.1097/MIB.0000000000000775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
355 Huo HJ, Chen SN, Li L, Laghari ZA, Li N, Nie P. Functional characterization of interleukin (IL)-22 and its inhibitor, IL-22 binding protein (IL-22BP) in Mandarin fish, Siniperca chuatsi. Developmental & Comparative Immunology 2019;97:88-97. [DOI: 10.1016/j.dci.2019.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
356 Peiravan A, Bertolini F, Rothschild MF, Simpson KW, Jergens AE, Allenspach K, Werling D. Genome-wide association studies of inflammatory bowel disease in German shepherd dogs. PLoS One 2018;13:e0200685. [PMID: 30028859 DOI: 10.1371/journal.pone.0200685] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
357 Frazer LC, Scurlock AM, Zurenski MA, Riley MM, Mintus M, Pociask DA, Sullivan JE, Andrews CW Jr, Darville T. IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis. Am J Reprod Immunol 2013;70:472-84. [PMID: 24238108 DOI: 10.1111/aji.12171] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
358 Pidasheva S, Trifari S, Phillips A, Hackney JA, Ma Y, Smith A, Sohn SJ, Spits H, Little RD, Behrens TW, Honigberg L, Ghilardi N, Clark HF. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One. 2011;6:e25038. [PMID: 22022372 DOI: 10.1371/journal.pone.0025038] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
359 Monteleone I, Pallone F, Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm 2009;2009:297645. [PMID: 19503799 DOI: 10.1155/2009/297645] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
360 Killig M, Glatzer T, Romagnani C. Recognition strategies of group 3 innate lymphoid cells. Front Immunol 2014;5:142. [PMID: 24744763 DOI: 10.3389/fimmu.2014.00142] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 7.1] [Reference Citation Analysis]
361 Dige A, Støy S, Rasmussen TK, Kelsen J, Hvas CL, Sandahl TD, Dahlerup JF, Deleuran B, Agnholt J. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. J Crohns Colitis 2013;7:248-55. [PMID: 22784949 DOI: 10.1016/j.crohns.2012.06.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
362 Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, Jongrakthaitae S, Akapirat S, Fletscher JL, Kroon E, Dewar R, Trichavaroj R, Chomchey N, Douek DC, O Connell RJ, Ngauy V, Robb ML, Phanuphak P, Michael NL, Excler JL, Kim JH, de Souza MS, Ananworanich J; RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 2014;10:e1004543. [PMID: 25503054 DOI: 10.1371/journal.ppat.1004543] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 23.6] [Reference Citation Analysis]
363 Perusina Lanfranca M, Lin Y, Fang J, Zou W, Frankel T. Biological and pathological activities of interleukin-22. J Mol Med (Berl) 2016;94:523-34. [PMID: 26923718 DOI: 10.1007/s00109-016-1391-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 13.2] [Reference Citation Analysis]
364 Shohan M, Dehghani R, Khodadadi A, Dehnavi S, Ahmadi R, Joudaki N, Houshmandfar S, Shamshiri M, Shojapourian S, Bagheri N. Interleukin-22 and intestinal homeostasis: Protective or destructive? IUBMB Life 2020;72:1585-602. [PMID: 32365282 DOI: 10.1002/iub.2295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
365 D'Alessio FR, Kurzhagen JT, Rabb H. Reparative T lymphocytes in organ injury. J Clin Invest 2019;129:2608-18. [PMID: 31259743 DOI: 10.1172/JCI124614] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
366 Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009;113:945-52. [PMID: 18931341 DOI: 10.1182/blood-2008-08-172155] [Cited by in Crossref: 205] [Cited by in F6Publishing: 192] [Article Influence: 15.8] [Reference Citation Analysis]
367 Wang C, Kang SG, HogenEsch H, Love PE, Kim CH. Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine. J Immunol 2010;184:5519-26. [PMID: 20400707 DOI: 10.4049/jimmunol.0903942] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
368 Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek A, Wetzke M. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment. Gut. 2014;63:567-577. [PMID: 23468464 DOI: 10.1136/gutjnl-2012-302853] [Cited by in Crossref: 175] [Cited by in F6Publishing: 139] [Article Influence: 21.9] [Reference Citation Analysis]
369 Tsai HC, Wu R. Mechanisms of Cholera Toxin in the Modulation of TH17 Responses. Crit Rev Immunol 2015;35:135-52. [PMID: 26351147 DOI: 10.1615/critrevimmunol.2015012295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
370 Henderson P, van Limbergen JE, Schwarze J, Wilson DC. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:382-95. [PMID: 20645321 DOI: 10.1002/ibd.21379] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
371 Striz I, Brabcova E, Kolesar L, Sekerkova A. Cytokine networking of innate immunity cells: a potential target of therapy. Clinical Science 2014;126:593-612. [DOI: 10.1042/cs20130497] [Cited by in Crossref: 133] [Cited by in F6Publishing: 50] [Article Influence: 19.0] [Reference Citation Analysis]
372 Sugimoto K. Role of STAT3 in inflammatory bowel disease. World J Gastroenterol. 2008;14:5110-5114. [PMID: 18777586 DOI: 10.3748/wjg.14.5110] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
373 Hofmann S, Rösen-wolff A, Tsokos G, Hedrich C. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clinical Immunology 2012;143:116-27. [DOI: 10.1016/j.clim.2012.02.005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
374 Chan IH, Jain R, Tessmer MS, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm JB, Pierce RH, Yearley JH, Mcclanahan TK, Phillips JH, Cua DJ, Bowman EP, Kastelein RA, Laface D. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol 2014;7:842-56. [DOI: 10.1038/mi.2013.101] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
375 Choi B, Sayeed HM, Islam SMS, Sohn S. Role of N-acetyl galactosamine-4-SO4, a ligand of CD206 in HSV-induced mouse model of Behçet's disease. Eur J Pharmacol 2017;813:42-9. [PMID: 28709621 DOI: 10.1016/j.ejphar.2017.07.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]